Correction: Initiating antiretroviral therapy for hiv at a patient's first clinic visit: The rapit randomized controlled trial (PLoS Med, (2016), 13(5), 10.1371/journal.pmed.1002015);Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial

PLoS Medicine

Volumn 13, Issue 5, 2016, Pages

  Rosen, Sydney ^a,b   Maskew, Mhairi ^b   Fox, Matthew P ^a,b   Nyoni, Cynthia ^b   Mongwenyana, Constance ^b   Malete, Given ^b   Sanne, Ian ^b   Bokaba, Dorah ^c   Sauls, Celeste ^b   Rohr, Julia ^a   Long, Lawrence ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Health Department   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AMBULATORY CARE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HOSPITAL; HUMAN; MALE; MIDDLE AGED; POINT OF CARE TESTING; PRIMARY HEALTH CARE; PROCEDURES; PUBLIC SECTOR; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; TIME FACTOR; TREATMENT OUTCOME; UTILIZATION; YOUNG ADULT;

ADULT; AMBULATORY CARE; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE TESTING; PRIMARY HEALTH CARE; PUBLIC SECTOR; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84971634633     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/JOURNAL.PMED.1002050     Document Type: Erratum

References (27)

1. Siedner MJ, Ng CK, Bassett I V, Katz IT, Bangsberg DR, Tsai AC, Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002–2013: a meta-analysis. Clin Infect Dis. 2014; 60:1120–1127. doi: 10.1093/cid/ciu1137 25516189
2. Plazy M, Dray-Spira R, Orne-Gliemann J, Dabis F, Newell M- L, Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa. Trop Med Int Health. 2014; 19:680–689. doi: 10.1111/tmi.12301 24654990
3. Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, et al. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013; 62: 39–46.
4. Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Wu Y, et al. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved. 2013; 24: 359–383. doi: 10.1353/hpu.2013.0014 23377739
5. INSIGHT START Study GroupInitiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015; 373: 795–807. doi: 10.1056/NEJMoa1506816 26192873
6. World Health OrganizationGuideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015.
7. Govindasamy D, Ford N, Kranzer K, Risk factors, barriers and facilitators for linkage to ART care in sub-Saharan Africa: a systematic review. AIDS. 2012; 26: 2059–2067. doi: 10.1097/QAD.0b013e3283578b9b 22781227
8. Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, et al. Rethinking the “‘pre’” in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS ONE. 2012; 7: e39894. doi: 10.1371/journal.pone.0039894 22761924
9. World Health OrganizationGlobal update on the health sector response to HIV, 2014. Geneva: World Health Organization; 2014.
10. Ingle SM, May M, Uebel K, Timmerman V, Kotze E, Bachmann M, et al. Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS. 2010; 24: 2717–2725. doi: 10.1097/QAD.0b013e32833fb71f 20935554
11. Myer L, Zulliger R, Pienaar D, Diversity of patient preparation activities before initiation of antiretroviral therapy in Cape Town, South Africa. Trop Med Int Heal. 2012; 17: 972–977. doi: 10.1111/j.1365-3156.2012.03033.x
12. National Department of HealthThe South African Antiretroviral Treatment Guideline 2013. Pretoria: National Department of Health; 2013.
13. Scott V, Zweigenthal V, Jennings K, Between HIV diagnosis and initiation of antiretroviral therapy: assessing the effectiveness of care for people living with HIV in the public primary care service in Cape Town, South Africa. Trop Med Int Heal. 2011; 16:1384–1391. doi: 10.1111/j.1365-3156.2011.02842.x
14. Gous N, Scott L, Potgieter J, Ntabeni L, Enslin S, Newman R, et al. Feasibility of performing multiple point of care testing for HIV anti-retroviral treatment initiation and monitoring from multiple or single fingersticks. PLoS ONE. 2013; 8: e85265. doi: 10.1371/journal.pone.0085265 24376873
15. Jani I V, Sitoe NE, Chongo PL, Alfai ER, Quevedo JI, Tobaiwa O, et al. Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. AIDS. 2011; 25:807–812. doi: 10.1097/QAD.0b013e328344f424 21378535
16. Mnyani CN, McIntyre JA, Myer L, The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy. J Acquir Immune Defic Syndr. 2012; 60: 260–264. doi: 10.1097/QAI.0b013e318256b651 22487589
17. Wade D, Daneau G, Aboud S, Vercauteren GH, Urassa WSK, Kestens L, et al. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 t-cell count systems : instrument performance and misclassification of HIV-infected patients. J Acquir Immune Defic Syndr. 2014; 66:98–107.
18. Scott LE, Campbell J, Westerman L, Kestens L, Vojnov L, Kohastsu L, et al. A meta-analysis of the performance of the Pima CD4 for point of care testing. BMC Med. 2015; 13:168. doi: 10.1186/s12916-015-0396-2 26208867
19. Meyer-Rath G, Schnippel K, Long L, Macleod W, Sanne I, Stevens W, et al. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS ONE. 2012; 7:e36966. 10.1371/journal.pone.0036966. doi: 10.1371/journal.pone.0036966 22693561
20. UNITAIDTuberculosis diagnostics technology and market landscape. Geneva: UNITAID; 2013.
21. Fox MP, Maskew M, MacPhail A, Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa. International Journal of Epidemiology. 2013; 42:430–439. doi: 10.1093/ije/dys029 22434860
22. Hoffmann CJ, Lewis JJ, Dowdy DW, Fielding KL, Grant AD, Martinson N, et al. Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model. J Acquir Immune Defic Syndr. 2013; 63:105–111. doi: 10.1097/QAI.0b013e3182893fb4 23392457
23. Jani I V, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: An observational cohort study. Lancet. 2011; 378:1572–1579. doi: 10.1016/S0140-6736(11)61052-0 21951656
24. Burtle D, Welfare W, Elden S, Mamvura C, Vandelanotte J, Petherick E, et al. Introduction and evaluation of a “pre-ART care” service in Swaziland: an operational research study. BMJ Open. 2012; 2:e000195. doi: 10.1136/bmjopen-2011-000195
25. Black S, Zulliger R, Myer L, Marcus R, Jeneker S, Hons BA, et al. Safety, feasibility and efficacy of a rapid ART initiation in pregnancy pilot programme in Cape Town, South Africa. S Afr Med J. 2013; 103:557–562. doi: 10.7196/SAMJ.6565 23885739
26. Mfinanga S, Chanda D, Kivuyo SL, Guinness L, Bottomley C, Simms V, et al. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet. 2015; 385:2173–2182. doi: 10.1016/S0140-6736(15)60164-7 25765698
27. Clouse K, Page-Shipp L, Dansey H, Moatlhodi B, Scott L, Bassett J, et al. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level. S Afr Med J. 2012; 102:805–807. doi: 10.7196/SAMJ.5851 23034211